Lenvatinib Impurity 21 | CAS 2023826-82-4 - Request Quote
Lenvatinib Impurity 21
| SZ CAT No: | SZ-L038035 |
| CAS No | 2023826-82-4 |
| Mol.F. | C12H11NO4 |
| Mol.Wt. | 233.2 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Lenvatinib Impurity 21 is chemically Methyl 4-hydroxy-7-methoxyquinoline-6-carboxylate. Lenvatinib Impurity 21 is supplied with detailed characterization data compliant with regulatory guideline. Lenvatinib Impurity 21 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Lenvatinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 2023826-82-4
Purchase 2023826-82-4
Order 2023826-82-4
Enquire 2023826-82-4
price of 2023826-82-4
2023826-82-4 Supplier
2023826-82-4 Manufacturer
2023826-82-4 Exporter
buy high quality Lenvatinib Impurity 21
Purchase Lenvatinib Impurity 21
Lenvatinib Impurity 21 suppliers
Lenvatinib Impurity 21 manufacturers
Lenvatinib Impurity 21 price
Order Lenvatinib Impurity 21
Enquire Lenvatinib Impurity 21
Lenvatinib Impurity 21 cost
Lenvatinib Impurity 21 Supplier
Lenvatinib Impurity 21 Distributor
Lenvatinib Impurity 21 for Method Validation
Lenvatinib Reference Standard
Lenvatinib Impurity 21 for ANDA Filing
Lenvatinib Impurity 21 for Forced Degradation Studies
Lenvatinib Impurity 21 Identification Standards
Lenvatinib Impurity 21 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.